Incidence of SARS-CoV-2 Infection Among Patients Undergoing Active Antitumor Treatment in Italy.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 33331862.
- Also identified by DOI 10.1001/jamaoncol.2020.6778 and PMC identifier 7747030.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This cohort study examines rates of SARS-CoV-2 infection among patients with cancer receiving antitumor treatment.
Medical subject headings
- Antineoplastic Agents
- COVID-19
- Neoplasms